Table 4.

Sex and age-specific prevalence of premorbid Metabolic Syndrome based on WHO proposal

	Prevalences of Pre-MetS
	Total (%)	Men (%)	Women (%)	p
Age ranges:
18-39 years	8.7 (14/161)	10.7 (8/75)	7.0 (6/86)	0.419
40-52 years	17.9 (30/168)	25.0 (21/84)	10.7 (9/84)	0.026
53-60 years	28.1 (43/153)	34.9 (22/63)	23.3 (21/90)	0.144
61-65 years	35.3 (49/139)	32.9 (25/76)	38.1 (24/63)	0.594
Total	21.9 (136/621)	25.5 (76/298)	18.6 (60/323)	0.041